Neurobiological Tech (NTII) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurobiological Tech (NTII)

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
1494	40	0	NTII

Emcee: Miles Rhyne Hoffman, CFA	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1144	Price Target: $10.00 03/03/2003 Memantine Regulatory Progress Proceeding, Ra	John McCarthy	-	3/4/2003
1143	2003 - [Diabetic Neuropathy][Amantadine Trial] Message 18603670 note:Amantadin	John McCarthy	-	2/19/2003
1142	Amgen, Given Imaging, MGI Pharma, Neurobiological Technologies In a prior aler	John McCarthy	-	2/19/2003
1141	Conference Call Alert PR Newswire, Tuesday, February 11, 2003 at 07:30 F	mopgcw	-	2/11/2003
1140	2003 - [Elan][New Vaccine][begin this year] Pharmaceuticals Elan Readies New As	John McCarthy	-	2/3/2003
1139	Excellent news today from FRX and NTII....now we are off to the races!	Arthur Radley	-	1/30/2003
1138	a tag on to mopgcw's post from the JM Dutton link ... Memantine for Diabeti	John McCarthy	-	1/22/2003
1137	Memantine for dementia (Cochrane Review). Two notes: (1) I edited the stuff be	John McCarthy	-	1/22/2003
1136	From JM Dutton: Rating: Buy Reason for Report: Regular Quarterly Update Basi	mopgcw	-	1/22/2003
1135	E. M. Krupitsky, MD, PhD; et. al Prior work with Heroin Ketamine Assisted Psy	John McCarthy	-	1/20/2003
1134	Addictive Disorders & Their Treatment Dec 2002; 1(4):143-146 A Pilot Study	John McCarthy	-	1/20/2003
1133	Memantine patent extension till 2014 (?) Most recently, an application from Mer	John McCarthy	-	1/19/2003
1132	emea - Memantine(Axura) characteristics 12/13/2002 emea.eu.int TopLevel .... e	John McCarthy	-	1/19/2003
1131	My best guess - NTII 2003 Timeline Milestones: $ Europe: $850,000 when sold in	John McCarthy	-	1/19/2003
1130	Larry - thanks for posting here - Believe it or not I just responded to you on	John McCarthy	-	1/17/2003
1129	All, In yesterday's earnings conference call, FRX said that they had update	lrb	-	1/17/2003
1128	Hi Marc - (if I could butt in) Our last quarter had this: Cash and Cash Equiv	John McCarthy	-	1/16/2003
1127	Dr. John thanks for posting (and I don't care what you would have said) it	John McCarthy	-	1/16/2003
1126	John, Nice to see you getting rewarded after exercising years of patience! I do	rkrw	-	1/16/2003
1125	Can you shed any light on the following apparent inconsistency. Yahoo's Pro	JMarcus	-	1/16/2003
1124	The buyout rumor is interesting because it makes sense. Paul Freiman has made no	Dr. John M. de Castro	-	1/16/2003
1123	The stock is certainly in a breakout mode. Message 18452107 I hadn't heard	JMarcus	-	1/16/2003
1122	Buyout rumor from JAGNOTES - Posted on Yahoo * BUYOUT RUMOR ** by: keepin	John McCarthy	-	1/16/2003
1121	'Postmarketing' by Makers of Alzheimer's Pill Raises Questions About	John McCarthy	-	1/14/2003
1120	from Washington post .... hard realities .... out of context (to be brief) For	John McCarthy	-	1/12/2003

Go to reply# or date (mm/dd/yy):